Co-Diagnostics Inc CODX

US Health Care

$1.07 ▼ -3.60% ($-0.04)

🎈 Low Float 🎢 High Beta

Open $1.09

Prev Close $1.11

Day Range $1.05 – $1.10

52W Range $0.91 – $46.50

Market Cap $7.64M

Beta 3.10

EPS (TTM) $-23.84

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	2017-07-12
Shares Out.	5,280,000
Website	codiagnostics.com/ ↗
Phone	18014381036
Employees	115
Revenue	$166,131
Gross Profit	$120,828
Net Income	-$6.3M
Free Cash Flow	-$27.5M
Total Assets	$16.6M
Total Liabilities	$3.9M
Equity	$12.7M

About Co-Diagnostics Inc

Co-Diagnostics Inc is a molecular diagnostics company. The company develops, manufactures, licenses, and commercializes reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules (DNA or RNA), including molecular tools for detection of infectious diseases. CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and others. The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.

Co-Diagnostics Inc is a publicly traded company under the ticker symbol CODX on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.